Category: Wall Street BeatSyndicate content

Ex-CEO Pignatelli backs down, but not out, in spat with Biolase

August 1, 2014 by Arezu Sarvestani

Scorned Biolase ex-CEO Federico Pignatelli withdraws his lawsuit as the company urges shareholders to welcome new leadership and deny his bid for re-election to the board.

Pignatelli backs down in spat with Biolase

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli agreed this week to withdraw his lawsuit against the dental devices maker, but he's still pursuing his personal investigation into the company's recent conduct.

Report: Lantheus spikes IPO plans

July 31, 2014 by Brad Perriello

Lantheus Medical Imaging spikes plans for a $125 million initial public offering, citing 'poor market conditions.'

Report: Lantheus spikes IPO plans

Lantheus Medical Imaging reportedly spiked an initial public offering it hoped would raise $125 million, citing "poor market conditions," Renaissance Capital reported.

Teleflex delivers a beat-and-raise Q2

July 31, 2014 by Arezu Sarvestani

Teleflex gets some Wall Street love after reporting double-digit revenue growth in Q2, beating analysts' expectations and raising its adjusted per-share earnings guidance for the rest of the year.

Teleflex delivers a beat-and-raise Q2

Wayne, Pa.-based Teleflex (NYSE:TFX) served up some good news today with strong numbers for its 2nd quarter and an increased outlook on the year.

The company posted an 11.4% increase in sales and an 11.3% increase in profits, with adjusted earnings coming in almost 19% higher year-over-year.

Smith & Nephew plans to reveal new strategy for mature markets | Medtech Wall Street news for the week of July 28, 2014

July 31, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Smith & Nephew CEO reveals new 'no frills' strategy; Bard: We're on track for early 2015 Lutonix approval; Ocular Therapeutix prices IPO below range; Philips' healthcare business suffers in Q2; Intersect ENT prices IPO at low end of range

Smith & Nephew CEO reveals new 'no frills' strategy

July 28, 2014 by Brad Perriello

T2 Biosystems boosts IPO cap to $78.2M

July 30, 2014 by Arezu Sarvestani

MRI diagnostics maker T2 Biosystems releases details on its initial public offering, hoping to raise as much as $78.2 million at $17 per share.

T2 Biosystems boosts IPO to $72.8M

Massachusetts-based  raised its hopes for its upcoming initial public offering, raising its maximum aggregate take to $78.2 million if shares sell at $17 apiece.

Edwards: Q2 brings double-digit sales bump, a major Medtronic settlement and a rosier outlook on the year

July 29, 2014 by Arezu Sarvestani

Edwards Lifesciences boosts its full-year guidance as sales surge in Q2, and the company pads its bottom line with a $750 million settlement from Medtronic.

Edwards: Medtronic TAVI settlement boosts bottom line in Q2

Edwards Lifesciences (NYSE:EW) bumped its expectations for the year after posting a strong 2nd quarter with significant increases in its sales and profits.

Philips' healthcare business suffers in Q2

July 28, 2014 by Arezu Sarvestani

Sluggish healthcare sales drag down Philips overall figures, but the company is eying a comeback for the 2nd half of the year.

Philips' healthcare business suffers in Q2

Philips Healthcare (NYSE:PHG) had a tough 2nd quarter with a shutdown of a manufacturing facility in Cleveland taking some of the wind out of the sales for the entire company.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp